Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo-Reference-Cited by-同舟云学术

Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo

Published:2012-03 Issue:6 Volume:83 Page:723-732
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Chattopadhyay Mitali,Kodela Ravinder,Nath Niharika,Barsegian Arpine,Boring Daniel,Kashfi Khosrow

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference78 articles.

1. Malignant tumors of the breast;Wood,2005

2. Global cancer statistics;Jemal;CA Cancer J Clin,2011

3. Tamoxifen in the treatment of breast cancer;Osborne;N Engl J Med,1998

4. Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers?;Sheikh;Invasion Metastasis,1994

5. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes;Carey;Clin Cancer Res,2007

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pills of Multi-Target H2S Donating Molecules for Complex Diseases;International Journal of Molecular Sciences;2024-06-27

2. Antineoplastic Effect of Valproic Acid: A Systematic Review of In Vivo Studies;Current Cancer Therapy Reviews;2024-06-11

3. The potential role of hydrogen sulfide in cancer cell apoptosis;Cell Death Discovery;2024-03-06

4. NF-κB in biology and targeted therapy: new insights and translational implications;Signal Transduction and Targeted Therapy;2024-03-04

5. Hydrogen sulfide: Recent development of its dual donors and hybrid drugs;British Journal of Pharmacology;2023-09